CO

Concentra Group Holdings Parent, Inc.

CONHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$2.16B
+13.9% YoY
Net Income
$166.4M
-0.1% YoY
EBITDA
$408.9M
+11.0% YoY
Free Cash Flow
$204.8M

Scan Results

Daily timeframe
DateIndicatorDetails
Aug 28 MACD Negative CrossoverHistogram -0.0771, negative momentum
Aug 27CONFIRMED MACD Negative CrossoverHistogram -0.0335, negative momentum
RSI OverboughtRSI 76.1, above 70, stock may be overbought
About Concentra Group Holdings Parent, Inc.

Operating under the Medical Care Facilities umbrella, Concentra Group Holdings Parent, Inc. is a healthcare company. Concentra Group Holdings Parent, Inc. With a market capitalization of $4.32B, it sits in mid-cap territory. provides occupational health services in the United States.

Where CON stands vs its 150-day and 200-day moving averages

As of the August 28, 2026 close, CON finished 32.24% above its 150-day moving average ($26.24) and 40.77% above its 200-day moving average ($24.65). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is CON overbought or oversold?

At the August 28, 2026 close, CON's RSI(14) was 56.6, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$4.32B
P/E (TTM)21.86
Fwd P/E18.51
EPS$1.55
Beta0.63
52W Change+59.4%
Dividend Yield0.73%
ROE47.1%
Analysis

The company holds $158.0M in cash, though total debt stands at $2.14B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $204.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 47.1% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $1.72B (2022) to $2.16B (2025), reflecting a 25% increase over the period.

With a beta below 0.7, Concentra Group Holdings Parent, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing CON's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms